These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 8902921)
1. Topiramate: a new antiepileptic drug for refractory epilepsy. Walker MC; Sander JW Seizure; 1996 Sep; 5(3):199-203. PubMed ID: 8902921 [TBL] [Abstract][Full Text] [Related]
2. A pharmacological and clinical review on topiramate, a new antiepileptic drug. Perucca E Pharmacol Res; 1997 Apr; 35(4):241-56. PubMed ID: 9264038 [TBL] [Abstract][Full Text] [Related]
4. Topiramate: a review of its use in childhood epilepsy. Ormrod D; McClellan K Paediatr Drugs; 2001; 3(4):293-319. PubMed ID: 11354701 [TBL] [Abstract][Full Text] [Related]
5. Topiramate: a new antiepileptic drug. Markind JE Am J Health Syst Pharm; 1998 Mar; 55(6):554-62. PubMed ID: 9544331 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study. Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581 [TBL] [Abstract][Full Text] [Related]
10. Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy. Langtry HD; Gillis JC; Davis R Drugs; 1997 Nov; 54(5):752-73. PubMed ID: 9360061 [TBL] [Abstract][Full Text] [Related]
11. Topiramate in refractory epilepsy: a prospective observational study. Stephen LJ; Sills GJ; Brodie MJ Epilepsia; 2000 Aug; 41(8):977-80. PubMed ID: 10961624 [TBL] [Abstract][Full Text] [Related]
12. Topiramate: a review of its use in the treatment of epilepsy. Lyseng-Williamson KA; Yang LP Drugs; 2007; 67(15):2231-56. PubMed ID: 17927286 [TBL] [Abstract][Full Text] [Related]
13. Topiramate: a review of preclinical, pharmacokinetic, and clinical data. Rosenfeld WE Clin Ther; 1997; 19(6):1294-308. PubMed ID: 9444441 [TBL] [Abstract][Full Text] [Related]
14. A pooled analysis of adjunctive topiramate in refractory partial epilepsy. Peeters K; Adriaenssen I; Wapenaar R; Neto W; Pledger G Acta Neurol Scand; 2003 Jul; 108(1):9-15. PubMed ID: 12807387 [TBL] [Abstract][Full Text] [Related]
15. Topiramate: a new antiepileptic drug. Privitera MD Ann Pharmacother; 1997 Oct; 31(10):1164-73. PubMed ID: 9337443 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of topiramate in refractory epilepsy: a long-term prospective trial. Tartara A; Sartori I; Manni R; Galimberti CA; Di Fazio M; Perucca E Ital J Neurol Sci; 1996 Dec; 17(6):429-32. PubMed ID: 8978450 [TBL] [Abstract][Full Text] [Related]
19. Topiramate pharmacokinetics in children and adults with epilepsy: a case-matched comparison based on therapeutic drug monitoring data. Battino D; Croci D; Rossini A; Messina S; Mamoli D; Perucca E Clin Pharmacokinet; 2005; 44(4):407-16. PubMed ID: 15828853 [TBL] [Abstract][Full Text] [Related]
20. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]